Roquefort Therapeutics (LON:ROQ) Trading 0.4% Higher – Should You Buy?

Roquefort Therapeutics plc (LON:ROQ)’s share price rose 0.4% during mid-day trading on Monday . The stock traded as high as GBX 3.99 ($0.05) and last traded at GBX 3.99 ($0.05). 17,350 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 516,817 shares. The stock had previously closed at GBX 3.97 ($0.05).

Roquefort Therapeutics Trading Up 0.4 %

The company has a current ratio of 0.79, a quick ratio of 3.07 and a debt-to-equity ratio of 12.37. The firm has a market capitalization of £5.15 million, a price-to-earnings ratio of -397.00 and a beta of 0.05. The firm’s 50-day moving average is GBX 3.99 and its 200 day moving average is GBX 4.26.

About Roquefort Therapeutics

Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action.